These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 33104035)

  • 1. Mechanisms and Clinical Applications of Glucocorticoid Steroids in Muscular Dystrophy.
    Quattrocelli M; Zelikovich AS; Salamone IM; Fischer JA; McNally EM
    J Neuromuscul Dis; 2021; 8(1):39-52. PubMed ID: 33104035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Inflammatory and General Glucocorticoid Physiology in Skeletal Muscles Affected by Duchenne Muscular Dystrophy: Exploration of Steroid-Sparing Agents.
    Herbelet S; Rodenbach A; Paepe B; De Bleecker JL
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32605223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent Glucocorticoid Dosing Improves Muscle Repair and Function in Mice with Limb-Girdle Muscular Dystrophy.
    Quattrocelli M; Salamone IM; Page PG; Warner JL; Demonbreun AR; McNally EM
    Am J Pathol; 2017 Nov; 187(11):2520-2535. PubMed ID: 28823869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent glucocorticoid steroid dosing enhances muscle repair without eliciting muscle atrophy.
    Quattrocelli M; Barefield DY; Warner JL; Vo AH; Hadhazy M; Earley JU; Demonbreun AR; McNally EM
    J Clin Invest; 2017 Jun; 127(6):2418-2432. PubMed ID: 28481224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Glucocorticoids in Murine Models of Duchenne and Limb-Girdle Muscular Dystrophy.
    Wintzinger M; Miz K; York A; Demonbreun AR; Molkentin JD; McNally EM; Quattrocelli M
    Methods Mol Biol; 2023; 2587():467-478. PubMed ID: 36401044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
    Manzur AY; Kuntzer T; Pike M; Swan A
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
    Manzur AY; Kuntzer T; Pike M; Swan A
    Cochrane Database Syst Rev; 2004; (2):CD003725. PubMed ID: 15106215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of glucocorticoid therapy on the inflammatory and dendritic cells in muscular dystrophies.
    Hussein MR; Hamed SA; Mostafa MG; Abu-Dief EE; Kamel NF; Kandil MR
    Int J Exp Pathol; 2006 Dec; 87(6):451-61. PubMed ID: 17222213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulsed glucocorticoids enhance dystrophic muscle performance through epigenetic-metabolic reprogramming.
    Quattrocelli M; Zelikovich AS; Jiang Z; Peek CB; Demonbreun AR; Kuntz NL; Barish GD; Haldar SM; Bass J; McNally EM
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31852847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids enhance muscle endurance and ameliorate Duchenne muscular dystrophy through a defined metabolic program.
    Morrison-Nozik A; Anand P; Zhu H; Duan Q; Sabeh M; Prosdocimo DA; Lemieux ME; Nordsborg N; Russell AP; MacRae CA; Gerber AN; Jain MK; Haldar SM
    Proc Natl Acad Sci U S A; 2015 Dec; 112(49):E6780-9. PubMed ID: 26598680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid Steroid and Alendronate Treatment Alleviates Dystrophic Phenotype with Enhanced Functional Glycosylation of α-Dystroglycan in Mouse Model of Limb-Girdle Muscular Dystrophy with FKRPP448L Mutation.
    Wu B; Shah SN; Lu P; Richardson SM; Bollinger LE; Blaeser A; Madden KL; Sun Y; Luckie TM; Cox MD; Sparks S; Harper AD; Lu QL
    Am J Pathol; 2016 Jun; 186(6):1635-48. PubMed ID: 27109613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study.
    McDonald CM; Henricson EK; Abresch RT; Duong T; Joyce NC; Hu F; Clemens PR; Hoffman EP; Cnaan A; Gordish-Dressman H;
    Lancet; 2018 Feb; 391(10119):451-461. PubMed ID: 29174484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids counteract hypertrophic effects of myostatin inhibition in dystrophic muscle.
    Hammers DW; Hart CC; Patsalos A; Matheny MK; Wright LA; Nagy L; Sweeney HL
    JCI Insight; 2020 Jan; 5(1):. PubMed ID: 31830002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect.
    Balaban B; Matthews DJ; Clayton GH; Carry T
    Am J Phys Med Rehabil; 2005 Nov; 84(11):843-50. PubMed ID: 16244521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid-Associated Demise of a Patient With Duchenne Muscular Dystrophy.
    Brahmsteadt AE; Bach JR; Pishdad R; Cespedes L; Pierucci P
    Am J Phys Med Rehabil; 2020 Dec; 99(12):e146-e148. PubMed ID: 32195738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice Recommendations.
    Bowden SA; Connolly AM; Kinnett K; Zeitler PS
    J Neuromuscul Dis; 2019; 6(1):31-41. PubMed ID: 30614808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considering the Promise of Vamorolone for Treating Duchenne Muscular Dystrophy.
    Grounds MD; Lloyd EM
    J Neuromuscul Dis; 2023; 10(6):1013-1030. PubMed ID: 37927274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glucocorticoid receptor N363S polymorphism and steroid response in Duchenne dystrophy.
    Bonifati DM; Witchel SF; Ermani M; Hoffman EP; Angelini C; Pegoraro E
    J Neurol Neurosurg Psychiatry; 2006 Oct; 77(10):1177-9. PubMed ID: 16980656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid therapy is associated with decreased numbers of dendritic cells and fibroblasts, and increased numbers of satellite cells, in the dystrophic skeletal muscle.
    Hussein MR; Abu-Dief EE; Kamel NF; Mostafa MG
    J Clin Pathol; 2010 Sep; 63(9):805-13. PubMed ID: 20819882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research.
    Muntoni F; Fisher I; Morgan JE; Abraham D
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S162-5. PubMed ID: 12206811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.